Novartis AG
Novartis AG (SIX: NOVN) is trading at CHF 121.40, about ₹14,048 at today's CHF/INR rate, as of 28 Sep 2026, 11:30 AM ET, up 1.34% today. Indian residents can buy Novartis from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
CHF 120.50
Today's high
CHF 122.12
52 week low
CHF 97.05
52 week high
CHF 132.68
NOVN opened at CHF 120.78, closed previously at CHF 119.80, and has traded between CHF 97.05 and CHF 132.68 over the past 52 weeks.
About
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with severe aplastic anemia (SAA); Tafinlar+Mekinist, an oral combination therapy to treat patients with certain types of cancers; and Jakavi for the treatment of myelofibrosis, polycythemia vera, and acute or chronic graftversushost disease (GvHD). It also provides Tasigna to treat philadelphia chromosomepositive chronic myeloid leukemia in the chronic and/or accelerated phase; Xolair for the treatment of allergic asthma and nasal polyps or severe chronic rhinosi nusitis with nasal polyps; Ilaris to treat fever syndromes, Still’s disease, and acute gouty arthritis; Pluvicto to treat prostatespecific membrane anti genpositive metastatic castrationresistant prostate cancer; Sandostatin SC and Sandostatin LAR to treat acromegaly carcinoid tumors and other types of functional gastro intestinal and pancreatic neuroendocrine tumors; Zolgensma for the treatment of genetic root cause of spinal muscular atrophy; Lucentis; Leqvio to reduce LDL cholesterol; Lutathera; Scemblix; and Fabhalta. The company focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, oncology, and hematology. It has a license and collaboration agreement with Alnylam Pharmaceuticals, Inc. to develop, manufacture, and commercialize Leqvio (inclisiran), a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.
Key statistics
Avg. volume
2.85M
Market cap
CHF 230.75B
P/E Ratio
22.15
Price-to-sales ratio
5.06
Enterprise value
$318.91B
Free cash flow yield
5.76%
Debt-to-equity ratio
1.18
Return on equity
29.64%
ROIC
13.38%
Beta
0.49
Dividend yield
3.05%
Last dividend
CHF 3.70
Financial overview
Revenue
$57.13B
Earnings per share
$7.56
Free cash flow
$18.43B
Net profit margin
23.09%
Gross margin
74.29%
EBITDA
$23.96B
Revenue growth
10.45%
Similar securities
This is not an investment recommendation
How to buy Novartis from India
Indian residents can buy Novartis shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to CHF.
Search for Novartis and place an order
Find Novartis by name or by its ticker, NOVN, and choose an order type. Novartis trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Novartis position in CHF and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Novartis from India
Trading and taxes when buying Novartis from India
Trading and limits
- Trading hours
- 9:00 am – 5:30 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Novartis’ current yield is 3.05%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Novartis stock?
Yes. Novartis (NOVN) has been listed on the SIX Swiss Exchange since 1996, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to CHF. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Novartis share cost in rupees?
One Novartis share is CHF 121.40 — about ₹14,048 at a CHF/INR rate of 115.72 on 27 Sep 2026. Both the Novartis price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Novartis from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Novartis shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the CHF/INR rate on the purchase and the sale date, so the rupee move counts alongside the Novartis price. Paasa issues a capital-gains statement for your return.
Does Novartis pay a dividend, and how is it taxed in India?
Yes. Novartis pays a dividend and the current yield is 3.05%; the last declared dividend was CHF 3.70 per share, about ₹428.16. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Novartis from India?
The SIX Swiss Exchange trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when Switzerland is on standard time. Orders can only execute during that window.
Do I have to declare Novartis shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Novartis holding, its cost and its closing value.
How do I sell Novartis and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in CHF in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on Novartis?
Yes. Novartis is priced in CHF, so your rupee outcome combines the CHF move with the CHF/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.